146 related articles for article (PubMed ID: 37832182)
1. Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
McLaughlin HD; Greco P; Straubhar AM; Rolston A; McCool K; Brackmann M; Siedel JH; McLean K; Reynolds RK; Uppal S
Gynecol Oncol; 2023 Nov; 178():89-95. PubMed ID: 37832182
[TBL] [Abstract][Full Text] [Related]
2. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
3. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Otten HM; Rutjes AW
Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
[TBL] [Abstract][Full Text] [Related]
4. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Shafa A; Watkins AB; McGree ME; Weroha SJ; Wahner Hendrickson AE; Block MS; Langstraat CL; McBane RD; Bakkum-Gamez JN; Kumar A
Gynecol Oncol; 2023 Sep; 176():36-42. PubMed ID: 37442024
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.
Wiegers HMG; Schaafsma M; Guman NAM; Zelisse HS; Mulder FI; Middeldorp S; van Es N; Mom CH
J Thromb Haemost; 2023 Feb; 21(2):294-302. PubMed ID: 36700503
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer.
Garas SN; McAlpine K; Ross J; Carrier M; Bossé D; Yachnin D; Mallick R; Cagiannos I; Morash C; Breau RH; Lavallée LT
Urol Oncol; 2022 Aug; 40(8):381.e1-381.e7. PubMed ID: 35581123
[TBL] [Abstract][Full Text] [Related]
7. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
[TBL] [Abstract][Full Text] [Related]
9. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
[TBL] [Abstract][Full Text] [Related]
10. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
[TBL] [Abstract][Full Text] [Related]
11. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
[TBL] [Abstract][Full Text] [Related]
12. The risk of venous thromboembolism in surgically treated hip fracture: A retrospective cohort study of 5184 patients.
Beauchamp-Chalifour P; Belzile ÉL; Michael R; Langevin V; Gaudreau N; Normandeau N; Bédard L; Pelet S
Orthop Traumatol Surg Res; 2022 Feb; 108(1):103142. PubMed ID: 34775033
[TBL] [Abstract][Full Text] [Related]
13. Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.
Chokshi SK; Gaughan JP; Krill L
J Thromb Thrombolysis; 2022 Jan; 53(1):202-207. PubMed ID: 34185227
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in women with ovarian cancer undergoing neoadjuvant chemotherapy prior to cytoreductive surgery: A retrospective study.
Oxley SG; Achampong YA; Sambandan N; Hughes DJ; Thomas M; Lockley M; Olaitan A
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2091-2096. PubMed ID: 34486103
[TBL] [Abstract][Full Text] [Related]
15. Venous Thromboembolism in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian Cancer and Impact on Survival.
Black KA; Ghosh S; Singh N; Chu P; Pin S
J Obstet Gynaecol Can; 2021 Dec; 43(12):1380-1387. PubMed ID: 34087490
[TBL] [Abstract][Full Text] [Related]
16. Perioperative Thromboprophylaxis Is Associated With Lower Risk of Venous Thromboembolism After Knee Arthroscopy.
Holler JT; Salesky M; Halvorson RT; Zhang AL; Ma CB; Feeley BT; Leavitt AD; Colyvas N; Lansdown DA
Arthroscopy; 2022 Dec; 38(12):3184-3191. PubMed ID: 35840070
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
Greco PS; Bazzi AA; McLean K; Reynolds RK; Spencer RJ; Johnston CM; Liu JR; Uppal S
Obstet Gynecol; 2017 Jun; 129(6):979-985. PubMed ID: 28486358
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol.
Chiang HA; Cheng PJ; Speed JM; Steinberg J; Najjar PA; Steele GS; Trinh QD; Eswara JR; Chang SL; Kibel AS; Stopfkuchen-Evans MF; Preston MA
Eur Urol Focus; 2020 Jan; 6(1):74-80. PubMed ID: 30228076
[TBL] [Abstract][Full Text] [Related]
19. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
20. Incidence of venous thromboembolism and bleeding after pulmonary lobectomy: evaluating the timing for thromboprophylaxis.
Smith D; Raices M; Diego C; Julián D; Montagne J; Dietrich A
J Thromb Thrombolysis; 2021 May; 51(4):997-1004. PubMed ID: 32929687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
